Stock Yards Bank & Trust Co. raised its position in shares of Humana Inc. (NYSE:HUM) by 5.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,799 shares of the insurance provider’s stock after buying an additional 620 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Humana were worth $2,264,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of HUM. Point72 Asia Hong Kong Ltd purchased a new position in Humana during the second quarter worth approximately $126,000. Daiwa SB Investments Ltd. increased its position in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock worth $129,000 after buying an additional 10 shares in the last quarter. Bessemer Group Inc. increased its position in Humana by 14.0% in the second quarter. Bessemer Group Inc. now owns 1,140 shares of the insurance provider’s stock worth $205,000 after buying an additional 140 shares in the last quarter. Fulton Bank N.A. purchased a new position in Humana during the third quarter worth approximately $229,000. Finally, BB&T Securities LLC increased its position in Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock worth $247,000 after buying an additional 165 shares in the last quarter. Hedge funds and other institutional investors own 91.71% of the company’s stock.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Shares of Humana Inc. (NYSE:HUM) traded up 0.96% during trading on Tuesday, hitting $210.00. The company had a trading volume of 1,732,240 shares. The stock has a market cap of $31.31 billion, a PE ratio of 28.40 and a beta of 0.80. Humana Inc. has a 12-month low of $150.00 and a 12-month high of $211.71. The firm has a 50 day moving average of $182.87 and a 200 day moving average of $177.74.

Humana (NYSE:HUM) last announced its earnings results on Friday, November 4th. The insurance provider reported $3.18 EPS for the quarter, topping the consensus estimate of $3.09 by $0.09. The business had revenue of $13.69 billion for the quarter, compared to the consensus estimate of $13.41 billion. Humana had a return on equity of 12.32% and a net margin of 2.00%. Humana’s revenue was up 2.5% compared to the same quarter last year. During the same period in the previous year, the business earned $2.16 EPS. On average, analysts forecast that Humana Inc. will post $9.51 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 27th. Stockholders of record on Thursday, January 12th will be issued a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 0.55%. The ex-dividend date is Tuesday, January 10th. Humana’s payout ratio is currently 15.96%.

TRADEMARK VIOLATION NOTICE: “Stock Yards Bank & Trust Co. Raises Position in Humana Inc. (HUM)” was first posted by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The legal version of this article can be viewed at

A number of research firms have commented on HUM. Credit Suisse Group AG reaffirmed a “hold” rating and set a $188.00 target price on shares of Humana in a report on Tuesday, September 13th. Barclays PLC reduced their target price on Humana from $193.00 to $191.00 and set an “equal weight” rating on the stock in a report on Thursday, August 4th. Jefferies Group reissued a “buy” rating and issued a $206.00 price target on shares of Humana in a report on Monday, November 7th. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a report on Monday, August 8th. Finally, JPMorgan Chase & Co. raised Humana from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $163.00 to $202.00 in a report on Thursday, November 10th. Five investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $205.00.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

5 Day Chart for NYSE:HUM

Want to see what other hedge funds are holding HUM? Visit to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with's FREE daily email newsletter.